Original Article

Subject Category: Oligonucleotide Therapy

Molecular Therapy (2008) 17 1, 162–168 doi:10.1038/mt.2008.220

Chitosan/siRNA Nanoparticle–mediated TNF-alpha Knockdown in Peritoneal Macrophages for Anti-inflammatory Treatment in a Murine Arthritis Model

Kenneth A Howard1,2, Søren R Paludan3, Mark A Behlke4, Flemming Besenbacher1, Bent Deleuran3 and Jørgen Kjems1,2

  1. 1Interdisciplinary Nanoscience Center (iNANO), University of Aarhus, Aarhus C, Denmark
  2. 2Department of Molecular Biology, University of Aarhus, Aarhus C, Denmark
  3. 3Department of Medical Microbiology and Immunology, University of Aarhus, Aarhus C, Denmark
  4. 4Integrated DNA Technologies, Inc. Coralville, Iowa, USA

Correspondence: Kenneth A Howard, Interdisciplinary Nanoscience Center, Ny Munkegade, Building 521, University of Aarhus, DK-800 Aarhus C, Denmark. E-mail: kenh@inano.dk

Received 2 May 2008; Accepted 12 September 2008; Published online 30 September 2008.

Top

Abstract

Secretion of tumor necrosis factor-alpha (TNF-alpha) by macrophages plays a predominant role in the development and progression of rheumatoid arthritis. We demonstrate that knockdown of TNF-alpha expression in systemic macrophages by intraperitoneal (i.p.) administration of chitosan/small interfering RNA (siRNA) nanoparticles in mice downregulates systemic and local inflammation. Chitosan nanoparticles containing an unmodified anti-TNF-alpha Dicer-substrate siRNA (DsiRNA) mediated TNF-alpha knockdown (~66%) in primary peritoneal macrophages in vitro. The presence of Cy3-labeled nanoparticles within peritoneal macrophages and specific TNF-alpha knockdown (~44%) with TNF-alpha siRNA after i.p. injection supports our therapeutic approach. Downregulation of TNF-alpha-induced inflammatory responses arrested joint swelling in collagen-induced arthritic (CIA) mice dosed i.p. with anti-TNF-alpha DsiRNA nanoparticles. The use of 2'-O-Me-modified DsiRNA resulted in the lowest arthritic scores and correlated with reduced type I interferon (IFN) activation in macrophages in vivo compared with unmodified DsiRNA. Histological analysis of joints revealed minimal cartilage destruction and inflammatory cell infiltration in anti-TNF-alpha-treated mice. The onset of arthritis could be delayed using a prophylactic dosing regime. This work demonstrates nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages as a method to reduce both local and systemic inflammation, thereby presenting a novel strategy for arthritis treatment.

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.

NEWS AND VIEWS

VIP: A very important protein in arthritis

Nature Medicine News and Views (01 May 2001)

Extra navigation

.

naturejobs

ADVERTISEMENT